Our aim has been to evaluate the effects of i.v. infusion of recombinant human erythropoietin ( rhEPO ) on the responses of growth hormone ( GH ) , prolactin ( PRL ) and thyrotropin ( TSH ) to thyrotropin-releasing hormone ( TRH ) stimulation in acromegalic patients .
